Why $AMRN retweeted Sept Lancet issue!!! – #stocks chatter


Why $AMRN retweeted Sept Lancet issue!!!
**Background: I couldn't figure why $AMRN retweeted the upcoming Lancet issue.**

$AMRN tweeted upcoming Sept Lancet issue [Link](https://twitter.com/TheLancetInfDis/status/1431573138249330694)

**Figured out why:**

The 2 Articles witin the Sept issue of the Lancet [Link](https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00376-X/fulltext)[ 1](https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00376-X/fulltext) [Link 2](https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00390-4/fulltext)

**Big reveal:**

**Both articles have connection to $AMRN, $PFE and HLS Therapeutics in them! Crazy how all three names are showing up together in the same articles in the Lancet! Especially since $PFE showed interest in $AMRN's drug working with HLS** [Link](https://www.newswire.ca/news-releases/hls-therapeutics-announces-promotional-agreement-with-pfizer-for-vascepa-r-in-canada-861060988.html)

FYI: Monday's dip is gonna be a feeding frenzy for me.


Please enter your comment!
Please enter your name here

10 + sixteen =

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.